Drug theft costs pharma $71B yearly

Counterfeit drugs and outright theft cost the pharmaceuticals industry some $71 billion a year, according to a new study from a consumer advocacy group known as America's Watchdog.

Counterfeiting alone pilfers some $70 billion from drug makers pockets, the group estimated. The remainder? A phenomenon known as "diversion," in which contract manufacturers agreed to make, say, 1 million pills but make 1.5 million instead, selling the extras on the black market--usually via the Internet. Drug makers are working hard to fight this problem, using RFID tags and other inventory control measures, the group said.

- see this article from in-PharmaTechnologist.com

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Novo Nordisk is betting big on GLP-1 Saxenda in its global obesity push, but England's cost watchdog is unimpressed with the drug's long-term outlook.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.